FDA Investigator Gretchen Lf Trendel

Gretchen Lf Trendel has conducted inspections on 24 sites in 2 countries as of 22 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
22 Apr 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
100003409
Countries of Inspections:
United States of America, France
FDA Investigators that have inspected at least one site in common with Gretchen Lf Trendel:
Adree N Anderson, Alan E Mehl, Alan L Truong, Amir A Abdalla, Amy E Devine, Ana Paulap Sandee, Andrew A Hoopes, Anthony R Bucks, Ashley A Mutawakkil, Barbara Janine Breithaupt, Brenda C Hamilton, Brent T Hall, Brett R Havranek, Brittany D Terhar, Candace S Tucker, Carl A Huffman, III, Carl J Montgomery, Charles L Zhou, Chilton L Ng, Chris A Sack, Cody D Rickman, Collins M Mason, Conner N Mann, Constantin Y Philopoulos, Cynthia M Goudeau, Dana D Carter, SR DDS, Danial S Hutchison, Daniel R Hurt, David J Eide, David L Miser, Dawn C Olenjack, Deidre R Edwards, Diane L Raccasi, Dr. Sriram Subramaniam, PhD, Edward E Lockwood (EEL), Erika V Butler, Evelyne L Weaver, Farhana Khan, Guerda Prophete, Gwyn G Dickinson, Ingrid Y Johnson, J Michael Cannon, PhD, James K Rice, Jamie L Dion, Jeffrey B Moody, Jessica E Hensley, Jill J Tillman, Jimmie L Weigand, John T Vonderbrink, José E Meléndez, Joseph A Piechocki, Joseph R Lambert, Julie N Vosilus, Karen C Daugherty, Kellia N Hicks, Laura S Huffman, Linda R Kuchenthal, Linhart, Lisa L Flores, Lisa L Gilliam, Lisa R Hilliar, Louis S Chen, Lucas B Leake, Marcus F Yambot, Marion D Wimberly, Jr, Martin K Yau, PhD, Mary L Schuckmann, Matthew M Schuckmann, Matthew R Sleeter, Megan M Kirk, Megan T Ziegler, Meisha Waters, Melinda L Rice, Melissa M Steiger, Michael A Feingold, Michael C Zubelewicz, Michael S Kopf, Michael S Smoker, Michele L Obert, Michele Perry Williams, Michele R Cromer, Monique M Brooks, Neal L Adams, Nicole C Mayfield, Patrick L Wisor, Richard L Rutherford, Rita K Kabaso, Robert J Ham, Robert J Mobley, Jr, Robin K Reel, Ruben C Ayala, PharmD, Sandra G Washko, Sandra G Wheat, Shafiq S Ahadi, Shanna R Haden, Sherry G Bous, Shirley J Berryman, Shwnji Susie Lee, Steven D Kehoe, Susanna E Ford, Susie H Lee, Tamara J Umscheid, Tara L Breckenridge, Tara L Greene, Tara L King, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Torrey M Ward, Veronica Fuentes, MS, Vickie J Kanion, Victoria A Wagoner, Vinh T Phan, Walsworth, Warren J Lopicka, Wayne D Mcgrath, Yiyue Zhang (nmi), PhD, Zachary A Bogorad

Gretchen Lf Trendel's Documents

Publish Date Document Type Title
November, 2022 FDA 483 Drivergent, Inc. - Form 483, 2022-11-03
May, 2021 FDA 483 Sterling Pharmaceutical Services, LLC - Form 483, 2021-05-14
April, 2022 FDA 483 Response Weeks & Leo Co., Inc. - Form 483R, 2022-04-27
June, 2023 FDA 483 Legacy Pharmaceutical Packaging, LLC - Form 483, 2023-06-30
May, 2021 EIR Sterling Pharmaceutical Services, LLC - EIR, 2021-05-14
January, 2022 FDA 483 Jost Chemical Co. - Form 483, 2022-01-21
December, 2022 FDA 483 TriRx Shawnee LLC - Form 483, 2022-12-14
January, 2022 FDA 483 Response Jost Chemical Co. - Form 483R, 2022-01-21
May, 2021 FDA 483 VVF Kansas Services LLC - Form 483, 2021-05-19
March, 2022 EIR Catalent CTS, LLC - EIR, 2022-03-04
April, 2022 EIR Weeks & Leo Co., Inc. - EIR, 2022-04-07
February, 2023 FDA 483 Chemdex, Inc - Form 483, 2023-02-27
April, 2022 FDA 483 Weeks & Leo Co., Inc. - Form 483, 2022-04-07
October, 2021 FDA 483 Hillyard GMP - Form 483, 2021-10-08
November, 2023 FDA 483 REPHARM LLC - Form 483, 2023-11-15
August, 2022 FDA 483 MRIGlobal - Form 483, 2022-08-29
April, 2021 FDA 483 Morton Salt, Inc. - Form 483, 2021-04-01
April, 2021 EIR Cardinal Health, Inc. - EIR, 2021-04-07
August, 2022 EIR MRIGlobal - EIR, 2022-08-26
June, 2022 FDA 483 Aquascience Technologies & Research, Inc - Form 483, 2022-06-16
September, 2024 FDA 483 Chem-Tech Ltd - Form 483, 2024-09-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more